Anzeige
Mehr »
Mittwoch, 21.01.2026 - Börsentäglich über 12.000 News
Gold über 4.862 USD - auf dem Weg zu 5.000 USD: Warum A2 Gold jetzt in eine neue Liga aufsteigt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12CNT | ISIN: SE0003656834 | Ticker-Symbol: M02
Stuttgart
19.01.26 | 15:27
0,040 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IZAFE GROUP AB Chart 1 Jahr
5-Tage-Chart
IZAFE GROUP AB 5-Tage-Chart

Aktueller Chart IZAFE GROUP Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
IZAFE GROUP AB-Investoren interessieren sich auch für diese Wertpapiere
INVO Fertility, Inc.: INVO Fertility Aligns Executive Leadership Structure to Support Growth StrategySARASOTA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation...
► Artikel lesen
INVO Fertility, Inc.: INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings"SARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition...
► Artikel lesen
INVO Fertility, Inc.: INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesSARASOTA, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. ("INVO" or the "Company") (NASDAQ: IVF), a healthcare company focused on the fertility market, today announced that it has entered...
► Artikel lesen
GeneDx to Participate in Upcoming Investor ConferencesGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Stifel...
► Artikel lesen
Progyny, Inc. Announces Third Quarter 2025 ResultsReports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and...
► Artikel lesen
Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and MenopauseGlobal employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health...
► Artikel lesen
Progyny, Inc. Announces Second Quarter 2025 ResultsReports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance...
► Artikel lesen